Cargando…
Pseudo‐Bartter syndrome in children with cystic fibrosis
Cystic fibrosis (CF) is an autosomal recessive genetic disorder. We report a case of a boy aged 4.5 years with cystic fibrosis, presenting under‐weightness, hypocalcemia, metabolic alkalosis, hypokalemia, and hyponatremia. Sweat analysis of the patients concluded pseudo‐Bartter syndrome, which was s...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552952/ https://www.ncbi.nlm.nih.gov/pubmed/31183080 http://dx.doi.org/10.1002/ccr3.2180 |
_version_ | 1783424707418128384 |
---|---|
author | Faraji‐Goodarzi, Mojgan |
author_facet | Faraji‐Goodarzi, Mojgan |
author_sort | Faraji‐Goodarzi, Mojgan |
collection | PubMed |
description | Cystic fibrosis (CF) is an autosomal recessive genetic disorder. We report a case of a boy aged 4.5 years with cystic fibrosis, presenting under‐weightness, hypocalcemia, metabolic alkalosis, hypokalemia, and hyponatremia. Sweat analysis of the patients concluded pseudo‐Bartter syndrome, which was successfully treated using antibiotics, physiotherapy, fluids, vitamin supplements, and pancreatic enzyme therapy. |
format | Online Article Text |
id | pubmed-6552952 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-65529522019-06-10 Pseudo‐Bartter syndrome in children with cystic fibrosis Faraji‐Goodarzi, Mojgan Clin Case Rep Case Reports Cystic fibrosis (CF) is an autosomal recessive genetic disorder. We report a case of a boy aged 4.5 years with cystic fibrosis, presenting under‐weightness, hypocalcemia, metabolic alkalosis, hypokalemia, and hyponatremia. Sweat analysis of the patients concluded pseudo‐Bartter syndrome, which was successfully treated using antibiotics, physiotherapy, fluids, vitamin supplements, and pancreatic enzyme therapy. John Wiley and Sons Inc. 2019-04-29 /pmc/articles/PMC6552952/ /pubmed/31183080 http://dx.doi.org/10.1002/ccr3.2180 Text en © 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Case Reports Faraji‐Goodarzi, Mojgan Pseudo‐Bartter syndrome in children with cystic fibrosis |
title | Pseudo‐Bartter syndrome in children with cystic fibrosis |
title_full | Pseudo‐Bartter syndrome in children with cystic fibrosis |
title_fullStr | Pseudo‐Bartter syndrome in children with cystic fibrosis |
title_full_unstemmed | Pseudo‐Bartter syndrome in children with cystic fibrosis |
title_short | Pseudo‐Bartter syndrome in children with cystic fibrosis |
title_sort | pseudo‐bartter syndrome in children with cystic fibrosis |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552952/ https://www.ncbi.nlm.nih.gov/pubmed/31183080 http://dx.doi.org/10.1002/ccr3.2180 |
work_keys_str_mv | AT farajigoodarzimojgan pseudobarttersyndromeinchildrenwithcysticfibrosis |